Stock Events

Stock Events

Xeris Biopharma (2B30.MU) Q2 2026 Earnings

7MayConfirmed

Q1 2026

Next

0

0.02

0.03

0.05

Details

Expected EPS

0.0000972306

Actual EPS

N/A

Surprise EPS

-0

Surprise Percent

+100%

Description

Xeris Biopharma (2B30.MU) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.